Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Toddler Alfie Evans' parents say they'll work with doctors

Apr 27, 2018

LONDON — The father of terminally ill toddler Alfie Evans said Thursday that he would work with doctors to give his son "dignity and comfort," as he called for a truce in a divisive case that has pitted doctors and the British courts against Alfie's parents, Christian groups and the pope. Tom Evans, 21, appealed for privacy "for everyone concerned," saying he would no longer make statements or give interviews about his son's case. "Our lives have been turned upside down by the intense focus on Alfie and his situation," Evans said outside Liverpool's Alder Hey Hospital, where Alfie has...

UK lawmakers call on Zuckerberg to appear before them

Apr 27, 2018

LONDON — The U.K. parliament's media committee demanded Facebook CEO Mark Zuckerberg appear before the panel after lawmakers said the senior executive who testified Thursday failed to fully answer their questions about the data protection scandal that has engulfed the company. Committee members didn't hide their frustration with Facebook's chief technical officer, Mike Schroepfer, who was forced to defend the company against suggestions that it was cavalier with user data and has done little to stem the spread of fake news. Facebook dispatched the unassuming engineer to London despite a previous request for Zuckerberg to appear. During a four-hour plus...

Palace: Prince William to be best man at Harry's wedding

Apr 27, 2018

LONDON — It's a family affair: Britain's royal officials say Prince Harry has asked elder brother Prince William to be best man at his wedding next month. Kensington Palace said Thursday that William is "honored" to be playing the key role when Harry marries U.S. actress Meghan Markle at Windsor Castle on May 19. Harry was best man when William married Kate Middleton at Westminster Abbey in 2011. William and his wife, the Duchess of Cambridge, welcomed their third child on Monday. The baby boy's name hasn't yet been announced. His elder children, Prince George and Princess Charlotte, are likely...

Facebook launches transparency tool before Irish referendum

Apr 27, 2018

LONDON — Facebook is launching a pilot program in Ireland ahead of a referendum on abortion which it hopes will ensure greater transparency in political advertising. The tool, which is also being tested in Canada, follows a scandal involving the political consultant Cambridge Analytica that has stoked concerns about privacy on the social network. One of the allegations in the Cambridge Analytica scandal was that data from millions of Facebook users was used to help micro-target political ads to select groups— meaning that only those most susceptible to the message would see the advertisements. The new tool being launched Wednesday...

Cambridge Analytica fights back on data scandal

Apr 27, 2018

LONDON — Cambridge Analytica unleashed its counterattack against claims that it misused data from millions of Facebook accounts, saying Tuesday it is the victim of misunderstandings and inaccurate reporting that portrays the company as the evil villain in a James Bond movie. Clarence Mitchell, a high-profile publicist recently hired to represent the company, held Cambridge Analytica's first news conference since allegations surfaced that the Facebook data helped Donald Trump win the 2016 presidential election. Christopher Wylie, a former employee of Cambridge Analytica's parent, also claims that the company has links to the successful campaign to take Britain out of the...

Sign up now!